Feed CGEMY
CG

Capgemini SE CGEMY OTC · Technology · France

$26.58 -3.26% -$0.90

Summary

54 / 100 · Bulios Score

What speaks for it

  • The share price is below the Bulios Fair Price.
  • It has raised its dividend 5 years in a row and pays out only 45% of profit.

What to watch

  • Revenue grew by only 0.7% a year over the last 3 years.
  • Out of every 100 EUR of revenue, only 5.8 EUR is left as net profit.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Undervalued Price today $26.58

By our assumptions the business is worth more than its shares cost today.

P/E today 15.0 27% lower
5-year average P/E 20.6
P/E today 15.0
Information Technology Services industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 15.0 EUR for 1 EUR of yearly profit. Over the last five years it was 20.6 EUR on average.

Valuation in detail

Is it growing?

It is shrinking

Revenue (EUR)

Diluted EPS (EUR)

  • Analyst estimate

Revenue grew by 7.2% a year over 5 years. Over the last 3 years it grew by 0.7% a year. For the next fiscal year analysts expect revenue to grow by 6.0%. Earnings per share fell by 0.2% a year over the last 3 years.

Growth in detail

Does it make money?

Poorly

Where 100 EUR of revenue goes

Net profit, industry median (Information Technology Services) 5.9 EUR

Out of every 100 EUR of revenue, 5.8 EUR is left as net profit.

Profitability in detail

Is it financially healthy?

Mostly

Repaying all its debt would take 4.6 years of free cash flow. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

High, stretched
Yield
3.01%
Paid out of profit
45%
Raised in a row
5 years

You receive $0.80 per share a year. The payout takes a large part of its profit or free cash flow.

Dividends in detail

What do analysts expect?

Neutral

No analyst has published a price target.

33% of the analysts recommend buying.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy